Comparison of the overall prevalence of ZNF217 mutations found in this and two other PMBCL studies with data reported in HL and DLBCL, indicate an enrichment of ZNF217 mutations in PMBCL (Fig. 1d). The gene discussed is ZNF217; the disease is Hodgkins lymphoma.